Structure-based design of anti-infectives.

Area of Science:

• Infectious disease research
• Drug discovery and development
• Computational chemistry

Background:

• Infectious diseases remain a leading global cause of mortality.
• Antimicrobial resistance threatens the efficacy of existing anti-infective drugs.
• A continuous pipeline of novel anti-infective agents is urgently required.

Purpose of the Study:

• To review the application of structure-based drug design (SBDD) in discovering new anti-infective agents.
• To highlight opportunities in antimalarial, antiviral, and antibacterial drug discovery using SBDD.
• To explore the potential of in silico methods in addressing drug resistance.

Main Methods:

• Review of current literature on SBDD in anti-infective research.
• Exploration of in silico approaches like virtual high-throughput screening.
• Analysis of de novo structure-based rational drug design strategies.

Main Results:

• SBDD is a powerful tool for identifying novel drug candidates.
• In silico methods accelerate the drug discovery process.
• SBDD provides a rational approach to overcome drug resistance.

Conclusions:

• Structure-based drug design presents significant opportunities for developing new antimalarial, antiviral, and antibacterial drugs.
• In silico approaches are crucial for combating the growing threat of drug resistance.
• This paradigm shift in drug design is vital for global health security.